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Hedgehog (HH) proteins are proteolytically processed
into a biologically active form that is covalently modi-
fied by cholesterol and palmitate. However, most
studies of HH biogenesis have characterized protein
from cells in which HH is overexpressed. We purified
Sonic Hedgehog (SHH) from cells expressing phy-
siologically relevant levels and showed that it was
more potent than SHH isolated from overexpressing
cells. Furthermore, the SHH in our preparations was
modified with a diverse spectrum of fatty acids on
its amino termini, and this spectrum of fatty acids
varied dramatically depending on the growth condi-
tions of the cells. The fatty acid composition of SHH
affected its trafficking to lipid rafts as well as its po-
tency. Our results suggest that HH proteins exist as
a family of diverse lipid-speciated proteins that might
be altered in different physiological and pathological
contexts in order to regulate distinct properties of
HH proteins.INTRODUCTION
The Hedgehog (HH) family of proteins plays diverse biological
roles that are conserved across different classes of animals (Ing-
ham andMcMahon, 2001). HH ligands are responsible for embry-
onic patterning as well as the maintenance, growth, and renewal
of various adult structures (Beachy et al., 2004; Ingham and
McMahon, 2001). HH proteins harboring missense mutations
have also been implicated in human developmental disorders
(Bale, 2002), and reactivation of their expression is required for
the viability of many cancers (Teglund and Toftga˚rd, 2010). Bio-1280 Cell Reports 10, 1280–1287, March 3, 2015 ª2015 The Authorschemically, the most extensively studied HH protein is Sonic
HH (SHH) (Farzan et al., 2008), which is produced as an
45 kDa pre-pro-protein that contains an amino-terminal signal
sequence targeting SHH to the secretory pathway (Chang et al.,
1994; Echelard et al., 1993; Krauss et al., 1993; Riddle et al.,
1993; Roelink et al., 1994). During SHH’s intracellular trafficking,
this signal sequence is cleaved off (Bumcrot et al., 1995). A 16 car-
bon fatty acid, palmitate (C16:0), was reported to modify this
newly exposed amino-terminal cysteine via a stable amide bond
(Pepinsky et al., 1998) in a reaction catalyzed by the SHH acyl-
transferase SkinnyHedgehog (Buglino andResh, 2008; Chamoun
et al., 2001). Although this palmitoylated, full-length form of SHH
has substantial activity (Tokhunts et al., 2010), the bulk of SHHun-
dergoes additional processing to yield an 24 kDa amino-termi-
nal form (Chang et al., 1994; Lo´pez-Martı´nez et al., 1995; Martı´
et al., 1995; Roelink et al., 1995). The latter processing step
occurs in an intramolecular fashion and results in the addition of
cholesterol to the newly exposed carboxyl-terminal glycine via a
labile ester bond (SHH-Np) (Lee et al., 1994; Porter et al., 1995).
Very little data regarding the biogenesis of endogenous HH
proteins have been published, likely because of the scarcity of
endogenous HH proteins and the difficulty of purifying and
analyzing such hydrophobic proteins. What is known about the
biogenesis of HH proteins is derived from studies in which HH
was purified from cells that were engineered to vastly overex-
press it (Pepinsky et al., 1998; Porter et al., 1996; Taipale et al.,
2000), or from analyses of recombinant HH proteins that lack
their hydrophobic modifications (Lee et al., 1994; Pathi et al.,
2001; Taylor et al., 2001). Here, we describe the purification of
a potent form of SHH-Np from cells that express endogenous-
like levels of SHH. Further, we show that this purified SHH-Np
actually consists of a family of proteins that are modified at their
amino-terminus by a diverse spectrum of saturated and unsatu-
rated fatty acids, and that these novel modifications dictate the
biology of HH proteins.
Figure 1. SHH-I Cells Produce Endogenous-like Levels of Potent
SHH-Np
(A) An immunoblot showing SHH-Np abundance in SHH-I cells under condi-
tions in which its expression was induced (+) or uninduced () with murister-
one. SHH-I parental cells, which are not engineered to express SHH, were
used as a control (Ctrl). GAPDH was used to verify protein normalization.
(B) An aliquot of SHH-I cellular lysate was tested for SHH-Np-associated ac-
tivity using the Light-II reporter cell line. SHH-Np activity measurements were
carried out in the linear range of this assay (see Figure S1B) and these activity
results were then normalized to overall SHH-Np levels to determine potency.
Error bars represent the SD in one representative experiment.
(C) SHH-Np levels from uninduced SHH-I cells and chick embryo limb buds
were compared by immunoblotting. During development, SHH-Np is pro-
duced in the posterior portion of limb buds (Post). Here, the anterior (Ant)
portion of limb buds serves as a negative control for SHH-Np. As only20%of
the posterior tissue consists of SHH-producing cells (Riddle et al., 1993), we
mixed 20%of SHH-I cell lysatewith 80%of lysate from anterior limb bud tissue
for this comparison. GAPDH was used to verify normalization.RESULTS
To identify a cell line expressing low levels of SHH, we first
compared the steady-state levels of SHH-Np for a previously
described cell line (SHH-I cells) that expresses SHH under the
control of a muristerone-inducible promoter (Taipale et al.,
2000; Figures 1A and S1A). SHH-I cells produced low levels of
SHH-Np in the absence of induction, presumably due to the pro-
miscuity of such inducible promoters, and these levels increased
20-fold in the presence of muristerone. We next compared the
activity of SHH-Np from cell lysates obtained with or without
muristerone treatment, measuring the ability of similar amounts
of SHH-Np to activate an engineered SHH reporter cell line
(Light-II cells) that drives Firefly luciferase expression (Taipale
et al., 2000; Figures 1B and S1B). The normalized potency of
SHH-Np produced under uninduced conditions was significantly
higher than that produced when its expression was induced by
muristerone. To compare the levels of SHH-Np produced by
SHH-I cells with those produced in a physiologically relevant
setting (Riddle et al., 1993), we compared the steady-state levels
of SHH-Np from uninduced SHH-I cells with those found in
dissected posterior and anterior halves of chick limb buds (Fig-
ure 1C). SHH-Np levels were similar for uninduced SHH-I cells
and posterior chick limb bud tissue.
Using published purification protocols (Pepinsky et al., 1998;
Taipale et al., 2000), wewere unable to purify SHH-Np from unin-Ceduced SHH-I cells expressing such low levels of SHH. Thus,
we modified these procedures to maximize the yield of active
SHH-Np from such cells. Uninduced SHH-I cells were dounce
homogenized in an isotonic, detergent-free buffer (Figure 2A)
to obtain a total lysate. This cellular lysate was further frac-
tionated by centrifugation at 100,000 3 g, producing cyto-
plasmic and membrane-enriched fractions. Similarly prepared
lysates of SHH-I parental cells, which do not express detectable
amounts of SHH, were used as a negative control. The bulk of
SHH-Np was in the membrane fraction, consistent with previous
reports (Taipale et al., 2000). Aliquots of these lysates, along with
the cytoplasmic or membrane-enriched fractions of these cells,
were volume normalized and then incubated with Light-II cells
to estimate the levels of active SHH in each fraction (data not
shown). The bulk of SHH activity was also found in the mem-
brane-enriched pellet.
Detergent extraction of the membrane fraction and purifica-
tion by centrifugation, ion exchange chromatography, and
affinity chromatography resulted in 5 ng of purified SHH-Np
per milligram of total cellular lysate (Figure 2B). We estimate
the purity of this preparation to be >95%, representing a
200,000-fold purification. The identity of the purified SHH-Np
was confirmed by tandem mass spectrometry (MS/MS; data
not shown). The vast majority of recovered peptides were
derived from the amino-terminal domain of SHH, with coverage
against the predicted amino acid sequence of SHH-N approach-
ing 90%. To compare the potency of the SHH-Np isolated here
with previously described values (Pathi et al., 2001; Pepinsky
et al., 1998; Taipale et al., 2000), we assayed the differentiation
of C3H10T1/2 embryonic fibroblasts into osteoblasts (Kinto
et al., 1997). The EC50 of SHH-Np purified from uninduced
SHH-I cells was 0.3 nM, whereas the EC50 of recombinant
SHH-N was 60 nM (Figure 2C). We also quantified the expres-
sion of the SHH target gene Gli1 as an indicator of activity
(Ingram et al., 2002), treating C3H10T1/2 cells with purified
SHH-Np (Figure 2D). From this analysis, we estimated the
EC50 of purified SHH-Np to be 0.2 nM. In both of these assays,
the potency of SHH-Np was significantly greater than previously
reported (Pathi et al., 2001; Pepinsky et al., 1998; Taipale et al.,
2000). Purified SHH-Np was also able to stimulate the prolifera-
tion of primary cerebellar granular neuron precursor cells (GPCs)
(Dahmane and Ruiz i Altaba, 1999), confirming its activity (Fig-
ure S2). Thus, our SHH-Np purification protocol isolates
biologically active, potent SHH-Np from cells expressing endog-
enous-like levels of SHH.
We speculated that the increased potency of SHH-Np purified
from uninduced SHH-Np cells might result from differential
amino-terminal fatty acid modifications, which can alter the ac-
tivity of recombinant SHH-N in vitro (Pathi et al., 2001; Taylor
et al., 2001). To investigate this possibility, we analyzed Lys-C-
digested, purified SHH-Np by liquid chromatography (LC)-MS/
MS using a high-resolution LTQ Orbitrap mass spectrometer.
The mass/charge ratios obtained during these analyses were
cross-referenced against expected unmodified masses of indi-
vidual peptides, and theMS/MS ofmodified forms was validated
manually (Table S1; Figures S3A–S3C). Contrary to previous re-
ports (Pepinsky et al., 1998; Taipale et al., 2000), we identified a
diverse assortment of saturated and unsaturated fatty acidll Reports 10, 1280–1287, March 3, 2015 ª2015 The Authors 1281
Figure 2. SHH-Np Purified from Low-Level
SHH-Expressing Cells Is Highly Active
(A) SHH-I cells or the SHH-I parental cell line
(Ctrl) were dounce homogenized under isotonic
conditions, and total lysate (left panel) was
separated by ultracentrifugation at 100,000 3 g
(right panel) to generate a cytosol-enriched
fraction (Cyt) and a membrane-enriched fraction
(Mem). These fractions were volume normalized
to that of the original cellular lysate and im-
munoblotted as indicated. Tubulin served as
a cytosolic protein control and the Na+/K+
transporter served as a membrane protein
control.
(B) Aliquots of the indicated fractions from various
steps of SHH-Np purification were separated by
SDS-PAGE, followed by visualization of proteins
by silver staining (TL, total lysate; S, 100,000 3 g
supernatant; M, combined 100,000 3 g pellet
detergent extract; FT, non-bound material; W,
column wash; E, column eluate). Recombi-
nant, unmodified SHH-N is shown as a control
(rSHH-N). Electrophoretic retardation of rSHH-N
relative to cholesterol-modified SHH-Np was
previously noted (Lee et al., 1994).
(C) The indicated amounts of purified SHH-Np
were incubated with C3H10T1/2 fibroblasts,
which differentiate into osteoblasts in response to SHH (squares: purified SHH-Np; circles: rSHH-N). Alkaline phosphatase activity, which is an indirect,
quantitative measurement of this differentiation, was then measured.
(D) The indicated amounts of purified SHH-Np were incubated with C3H10T1/2 fibroblasts, followed by RNA extraction. The levels ofGli1 andGAPDHwere then
determined by qRT-PCR. Error bars represent the SD in one representative experiment.
See also Figure S2.modifications on SHH-Np. Based on extracted ion chromato-
gram (XIC) peak areas, the most abundant fatty acid-modified
forms of SHH-Np were modified with palmitate (C16:0), a palmi-
toleoyl (C16:1), followed by a stearoleyl (C18:1), a myristoleyl
(C14:1), and then to a lesser degree, a stearoyl (C18:0) and myr-
istoyl (C14:0) groups. A number of amino-terminal peptides
showed masses encompassing as yet undetermined modifica-
tions, consistent with SHH-Np being modified by a diversity of
lipid species.
To extend these findings, we also purified SHH-Np fromSHH-I
cells induced to express higher levels of SHH (1) in the presence
of 10% fetal bovine serum (FBS), (2) in the presence of serum-
free media, and (3) in the presence of serum-free media supple-
mented with myristate (C14:0). The pattern of lipid speciation on
SHH-Np changed significantly under all of these conditions, sug-
gesting that the lipid speciation of SHH is very sensitive to the
cellular context (Figure 3). We noted that unsaturated fatty
acid-modified SHH-Np was the dominant species regardless
of the cellular context, whereas the abundance of SHH-Np forms
modified with saturated fatty acids was significantly more vari-
able. Interestingly, the fatty acid modifications on SHH-Np iso-
lated from cells that expressed high levels of SHH and were
grown in FBS approximately mirrored the abundance of fatty
acids found in the membranes of cells grown in FBS, whereas
the lipid-speciated forms of SHH-Np purified from cells grown
under the other conditions did not. We further noted that
SHH-Np isolated from cells grown under serum-free conditions
but supplemented with myristate (C14:0) showed an 500% in-
crease of myristate-modified SHH-Np (data not shown), consis-1282 Cell Reports 10, 1280–1287, March 3, 2015 ª2015 The Authorstent with our ability to experimentally manipulate the fatty acid
speciation of SHH-Np. Significantly, we did not detect an
amino-terminal peptide lacking fatty acid modifications in these
experiments. Although MS is not generally quantitative, the
abundance of the same peptide in different samples may be
quantitatively compared (Old et al., 2005). Therefore, the ab-
sence of an unmodified amino-terminal peptide in our extracted
chromatograms suggests that SHH-Np is quantitatively modi-
fied by fatty acids in these cells.
The hydrophobic properties of the various fatty acid modifica-
tions we observed on SHH-Np vary over a 500-fold range (Table
S1), suggesting that they would alter the biological properties of
SHH-Np. Further, unsaturated fatty acids, such as those found
on SHH-Np, are known to segregate away from lipid rafts (Lev-
ental et al., 2010), where HH proteins are thought to enrich as
part of their regulated intracellular movement (Callejo et al.,
2011; Creanga et al., 2012; Mao et al., 2009; Rietveld et al.,
1999; Taipale et al., 2000). To test this hypothesis, we altered
the fatty acid composition of media used with cells or chick
limb bud explants expressing SHH, and then measured various
properties of the resulting SHH-Np. Such lipid-doping experi-
ments have previously been used to alter the covalent lipid mod-
ifications of numerous proteins (Hashimoto et al., 2004; Liang
et al., 2001; Wolven et al., 1997) before determining changes in
their biological function.We therefore incubated serum-deprived
SHH-I cells with saturated C14:0, C16:0, C18:0, or unsaturated
C16:1 fatty acids, and examined the levels of SHH-Np in both
cell lysates and secreted from those cells into conditioned me-
dia. Although we did not observe changes in the absolute levels
Figure 3. Fatty Acid Speciation of SHH-Np
Is Dependent on the Cellular Context
(A) A schematic showing the procedure used to
identify the fatty acid modification on SHH-Np.
(B–D) Pie charts showing the relative abundance
of lipid species identified on SHH-Np that was
purified and isolated under three different cellular
contexts: 10% FBS without muristerone induction
of SHH expression, 10% FBS and muristerone
induction of SHH expression, and serum de-
privation and muristerone induction of SHH
expression.
See also Figure S3 and Table S1.of cell-associated SHH-Np when cells were doped with different
fatty acids, consistent with previous reports (Bumcrot et al.,
1995), we did observe differences in the secretion of SHH-Np
forms from cells incubated with different fatty acids (Figure 4A).
Because lipid raft localization is thought to be a prerequisite for
the secretion of HH proteins (Callejo et al., 2011; Creanga et al.,
2012; Rietveld et al., 1999), we asked whether the various fatty
acid-modified SHH-Np forms would differentially localize to lipid
rafts. Therefore, we fractionated the cellular lysates of cells incu-
bated with various fatty acids over an OptiPrep gradient to
isolate lipid raft-enriched fractions (Figure 4B and data not
shown). Incubation of uninduced SHH-I cells with any of the
tested saturated fatty acids (C14:0, C16:0, or C18:0) increased
the percentage of SHH-Np that was enriched in lipid rafts (Fig-
ure 4C). In contrast, incubation of SHH-I cells with palmitoleate
(C16:1) reduced the percentage of SHH-Np that was enriched
in lipid rafts. Similar experiments were performed on anterior or
posterior chick limb bud explants. Consistent with our SHH-I
cell-based observations, treatment of the explants with unsatu-
rated C16:1 resulted in decreased SHH-Np localization to lipid
rafts in posterior tissue (Figure 5A). Although incubation of tissue
explants with saturated fatty acids had no effect on steady-state
SHH-Np levels, increased levels of tissue SHH-Np were ob-
served upon palmitoleoyl (C16:1) incubation. The mRNA levels
of SHH were unchanged by incubation with different fatty acids
(data not shown). These results are consistent with decreased
secretion of palmitoleoyl (C16:1)-modified SHH-Np, resulting in
increased retention in posterior limb bud tissue. We further
measured the activity of SHH-Np from these tissues and normal-
ized this activity to their relative abundance (Figures 5B and 5C).
This analysis showed that incubation of posterior limb bud frag-
ments with C16:1 reduced SHH-Np activity.
DISCUSSION
We now demonstrate that SHH-Np is actually a family of distinct
lipid-speciated forms that exhibit a variety of differential proper-
ties. Thus, we favor the idea that modification of SHH-Np by a
spectrum of fatty acids provides another biologically relevant
layer of SHH-Np regulation. Although the spectrum of fattyCell Reports 10, 1280–128acid modifications on SHH-Np was not
initially described in previous studies, a
similar spectrum of modifications for a
small percentage of the SHH mutantSHH-N, which is a non-physiologically relevant form of SHH
that is not cholesterol modified, was described (Pepinsky
et al., 1998). We speculate that differences in purification proto-
cols or levels of expression resulted in the identification of only
the most abundant, palmitoyl-modified form of SHH-Np in these
previous reports. For example, one of the previous purification
protocols for SHH-Np started with a lipid-raft-enriched fraction
(Taipale et al., 2000), which based on our data might exclude
SHH-Npmodified by unsaturated fatty acids. How such differen-
tial forms of SHH-Np might arise is also not yet clear. However,
in vitro, Skinny Hedgehog is able to utilize a wide spectrum
of fatty acids, many of which have a higher affinity for Skinny
Hedgehog than palmitate (Buglino and Resh, 2008). Interest-
ingly, the potency of recombinant forms of SHH-N is altered
when it is modified by different fatty acids in vitro (Taylor et al.,
2001). This observation is consistent with Skinny Hedgehog be-
ing sufficient to modify SHH with the diverse spectrum of fatty
acids described here.
Our findings suggest that one consequence of SHH-Np’s fatty
acid speciation is the regulation of its intracellular trafficking, with
decreased localization of SHH-Np modified with unsaturated
fatty acids to lipid rafts. This decreased localization is likely the
result of unsaturated fatty acids lacking the compactness
required to enrich in lipid raft compartments of cellular mem-
branes (Levental et al., 2010), although such fatty acid doping
experiments likely result in the production of a number of
different fatty acylated species. However, a simple differential
localization of SHH-Np proteins to the lipid raft or non-lipid raft
compartments of cellular membranes could arise solely by regu-
lating the degree of fatty acid saturation on SHH-Np. One
observed functional consequence of this differential localization
is the secretion of lipid-raft-localized SHH-Np forms and the
retention of raft-excluded forms. Such SHH-Np speciation might
then contribute to the gradient of SHH-Np observed in vivo (Gri-
tli-Linde et al., 2001), with SHH-Npmodified with the least hydro-
phobic fatty acids moving farther away from the SHH-producing
cells than SHH-Np family members modified with more hy-
drophobic fatty acids. In such a scenario, different fatty acid
modifications might modulate SHH-Np’s affinity for the various
lipoprotein complexes that have been suggested to regulate7, March 3, 2015 ª2015 The Authors 1283
Figure 4. Fatty Acid Speciation of SHH-Np
Alters Its Lipid Raft Enrichment
(A) An immunoblot of cell lysates and conditioned
media from SHH-I cells incubated in the presence
of indicated fatty acids. GAPDH served as a
normalization control for cellular lysates. The same
volume of conditioned media was subjected to
TCA precipitation prior to loading.
(B) Lysates from SHH-I cells incubated with the
indicated lipids or DMSO control were separated
over an OptiPrep gradient to isolate a lipid-raft-
enriched fraction. Fractions from these various
OptiPrep density gradients were resolved by SDS-
PAGE and then analyzed by immunoblotting for
SHH-Np, GAPDH as a cytoplasmic protein marker,
or the lipid raft marker flotillin. Note that flotillin
localization did not change with various lipid ad-
ditions.
(C) Quantification of SHH-Np lipid raft enrichment
from cells incubated with the indicated fatty acids.
Error bars represent the SEM of three independent
experiments; p values % 0.05 are considered
statistically significant and are indicated by an
asterisk.the movement of HH proteins (Callejo et al., 2008; Gradilla et al.,
2014; Guerrero and Chiang, 2007; Matusek et al., 2014; Palm
et al., 2013; The´rond, 2012; Zeng et al., 2001). Alternatively, fatty
acid speciation of SHH-Np might alter its targeting ‘‘barcode’’
(Kornberg, 2011), allowing it to associate with diverse types of
lipid microdomains enriched on the cytonemes that are respon-
sible for HH movement (Fifadara et al., 2010; Gupta and De-
Franco, 2003; Kornberg, 2013; Sanders et al., 2013). In either
model, the fatty acid speciation of SHH described here might
be utilized to encode dramatic changes in cellular growth and
metabolism, such as those that occur during early development
or cancer, directly into the HH proteins that regulate these bio-
logical processes.
EXPERIMENTAL PROCEDURES
Comparison of SHH-Np Levels
Fertile, certified research-grade, pathogen-free eggs (Charles River) were
incubated at 37.5C. At Hamburger-Hamilton (H&H) developmental stage 22,
embryos were isolated and the limb buds were resected as previously
described (Zeng et al., 2001). Resected buds were further divided into SHH-
producing posterior and SHH-negative anterior portions, and lysed by suspen-
sion in 1% Tx-100, 10 mM sodium phosphate, 150 mM NaCl buffer, pH 7.4,
supplemented with protease inhibitors (Roche). Immunoblotting was per-
formed using anti SHH-Np polyclonal H-160 antibodies (Santa Cruz).
Purification of SHH-Np
SHH-I cells (Taipale et al., 2000) were washedwith PBS, collected by scraping,
dounce homogenized, and centrifuged at 100,000 3 g for 1 hr. The resultant
pellet was resuspended in buffer A and recentrifuged, and the membrane-en-
riched pellet was extracted twice with buffer B by dounce homogenization and
centrifugation at 16,0003 g for 30 min. The supernatants were combined, pH
adjusted to 5.0 with 1 M 2-[N-morpholino]ethanesulfonic acid (MES), and
applied to a bulk SP Sepharose Fast Flow resin. This resin was washed
once with buffer C, followed by a second wash with buffer D. SHH-Np was
eluted from this resin using buffer E. The eluted fractions were adjusted to
pH 7.2 with 1 M HEPES, and then passed through a 5E1 monoclonal antibody1284 Cell Reports 10, 1280–1287, March 3, 2015 ª2015 The Authors(mAb) column (Ericson et al., 1996). After the columnwaswashedwith buffer F,
the SHH-Np was eluted with buffer G and then immediately neutralized with
1 M HEPES, pH 7.4. Please refer to the Supplemental Experimental Proce-
dures for details regarding buffers A–G.
After SDS-PAGE, the purified SHH-Np was quantified by comparing its con-
centration against a standard curve of recombinant SHH-II (R&D). This gel was
subsequently protein stained using a SilverQuest staining kit (Invitrogen). The
optical density of each stained protein was then calculated and compared us-
ing ImageJ software (NIH). SHH activity measurements were performed
essentially as described previously (Singh et al., 2009), using NIH 3T3 cells
expressing an HH reporter gene (Light-II cells). SHH-Np-dependent differenti-
ation and gene expression were assayed using the C3H10T1/2 cell line as pre-
viously described (Zeng et al., 2001). All activity measurements were done in
triplicate and each experiment was repeated at least three times. The activity
data presented are shown as the mean and SD of one representative
experiment.
MS Analyses
The identity of the purified SHH-Np was validated by microcapillary liquid
chromatography/MS (LC/MS) on a ThermoFinnigan LTQ ion trap mass spec-
trometer. For identification of fatty acid modifications, SHH-Np was reduced
with 4 mM DTT, alkylated with 15 mM iodoacetamide, and EndoLysC di-
gested. Lipid modified peptides were identified by MS/MS analysis on a
LTQ-Orbitrap (Thermo) interfaced with an Eksigent nanoLC-2D HPLC. MS/
MS spectra were searched against the SHH protein sequence using a Mascot
(v 2.1) error-tolerant search with 20 ppm parent mass accuracy, and Inspect/
MS-Alignment run in blind modification search mode (Tanner et al., 2006). All
MS/MS spectra peptide assignments were manually verified for peptide
assignments.
Lipid Treatments
SHH-I cells were serum deprived for 6–7 hr in 0.5% FBS. Prior to lipid treat-
ment, the cells were washed with PBS once and then maintained in the pres-
ence of 100 mM fatty acids or DMSO (vehicle) for 16–18 hr (Liang et al., 2001).
For embryonic tissue studies, 10–12 pathogen-free H&H developmental
stage 22 chick embryos (Charles River) were collected (Zeng et al., 2001)
and posterior fragments of the limb buds were dissected as previously
described (Zeng et al., 2001). These posterior tissues were incubated with
100 mM fatty acids or DMSO (vehicle) for 16–18 hr in six-well plates. These
Figure 5. Modification of SHH-Np with
Distinct Fatty Acids Alters Its Functionality
(A) Lysates from embryonic limb bud explants
exposed to different fatty acids were separated
over an OptiPrep density gradient to isolate the
lipid raft fraction. Various gradient fractions were
resolved by SDS-PAGE and then analyzed by
immunoblotting for SHH-Np. Caveolin-1 was used
as a lipid raft marker, and GAPDH served to label
non-lipid-raft-associated subcellular fractions.
Treatment with saturated fatty acids did not
change the SHH-Np localization pattern
compared with the DMSO control (data not
shown).
(B) Upper panel: an immunoblot of limb bud ly-
sates shows the effect of lipid modifications on
SHH-Np levels. Lower panel: the lysates contain
similar amounts of total protein, as indicated by
total protein silver staining.
(C) The potency of SHH-Np was determined by
incubating lysates from treated limb buds with
Light-II cells and then normalizing this activity to
SHH-Np levels. Error bars represent the SEM of
three independent experiments; p values % 0.05
are considered statistically significant and are
indicated by an asterisk.tissues were subsequently washed twice in ice-cold PBS and homogenized in
a 1% Tx-100, 10 mM sodium phosphate, 150 mM NaCl buffer (pH 6.5).
OptiPrep Density Gradient Ultracentrifugation
Cell or tissue extract was mixed with OptiPrep medium to obtain a 40% frac-
tion. Then two other fractions, composed of 25% and 10% OptiPrep medium
or 30% and 0% for tissue extract, were sequentially layered on top followed by
centrifugation at 120,0003 g, or 160,0003 g for tissue extract, for 21 hr (Bru-
se´s et al., 2001; Chen et al., 2004; Lisanti et al., 1994). Fractions from the tubes
were collected and subjected to SDS-PAGE analysis.
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